213 related articles for article (PubMed ID: 27006301)
1. Activating BRAF Mutations Detected in Mixed Hürthle Cell Carcinoma and Multifocal Papillary Carcinoma of the Thyroid Gland: Report of an Unusual Case and Review of the Literature.
Sinno S; Choucair M; Nasrallah M; Wadi L; Jabbour MN; Nassif S
Int J Surg Pathol; 2016 Sep; 24(6):519-24. PubMed ID: 27006301
[TBL] [Abstract][Full Text] [Related]
2. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS
Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
[TBL] [Abstract][Full Text] [Related]
4. Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K.
Han F; Zhang L; Zhang S; Zhou H; Yi X
Int J Clin Exp Pathol; 2015; 8(5):5896-901. PubMed ID: 26191315
[TBL] [Abstract][Full Text] [Related]
5. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
6. Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci.
Park SY; Park YJ; Lee YJ; Lee HS; Choi SH; Choe G; Jang HC; Park SH; Park DJ; Cho BY
Cancer; 2006 Oct; 107(8):1831-8. PubMed ID: 16983703
[TBL] [Abstract][Full Text] [Related]
7. EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.
Topf MC; Wang ZX; Furlong K; Miller JL; Tuluc M; Pribitkin EA
Endocr Pathol; 2018 Mar; 29(1):27-29. PubMed ID: 28965201
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathology of well-differentiated thyroid carcinomas.
Sobrinho-Simões M; Preto A; Rocha AS; Castro P; Máximo V; Fonseca E; Soares P
Virchows Arch; 2005 Nov; 447(5):787-93. PubMed ID: 16189702
[TBL] [Abstract][Full Text] [Related]
9. Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant.
Smith RA; Salajegheh A; Weinstein S; Nassiri M; Lam AK
Hum Pathol; 2011 Apr; 42(4):500-6. PubMed ID: 21167555
[TBL] [Abstract][Full Text] [Related]
10. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.
Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB
Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280
[TBL] [Abstract][Full Text] [Related]
11. Multicentric occurrence of multiple papillary thyroid carcinomas--HUMARA and BRAF mutation analysis.
Nakazawa T; Kondo T; Tahara I; Kasai K; Inoue T; Oishi N; Mochizuki K; Kubota T; Katoh R
Cancer Med; 2015 Aug; 4(8):1272-80. PubMed ID: 25882744
[TBL] [Abstract][Full Text] [Related]
12. Follicular variant of papillary thyroid carcinoma with B-type Raf(V600E) showing higher frequency of suspicious sonographic features and multifocality.
Shin DY; Kim KJ; Chang S; Kim H; Hwang S; Kim W; Bae J; Park S; Kang SW; Chung WY; Lee EJ
Head Neck; 2015 Nov; 37(11):1590-5. PubMed ID: 24909403
[TBL] [Abstract][Full Text] [Related]
13. BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma.
Pennelli G; Vianello F; Barollo S; Pezzani R; Merante Boschin I; Pelizzo MR; Mantero F; Rugge M; Mian C
Thyroid; 2011 Dec; 21(12):1393-6. PubMed ID: 22136270
[TBL] [Abstract][Full Text] [Related]
14. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures.
Cracolici V; Mujacic I; Kadri S; Alikhan M; Niu N; Segal JP; Rosen LE; Sarne DH; Morgan A; Desouky S; Cipriani NA
Endocr Pathol; 2018 Mar; 29(1):9-14. PubMed ID: 28710706
[TBL] [Abstract][Full Text] [Related]
15. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma.
Kim TY; Kim WB; Song JY; Rhee YS; Gong G; Cho YM; Kim SY; Kim SC; Hong SJ; Shong YK
Clin Endocrinol (Oxf); 2005 Nov; 63(5):588-93. PubMed ID: 16268813
[TBL] [Abstract][Full Text] [Related]
16. BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas.
Takano T; Ito Y; Hirokawa M; Yoshida H; Miyauchi A
Br J Cancer; 2007 May; 96(10):1549-53. PubMed ID: 17453004
[TBL] [Abstract][Full Text] [Related]
17. Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management--A Case Report.
Shrestha RT; Karunamurthy A; Amin K; Nikiforov YE; Caramori ML
Thyroid; 2015 Dec; 25(12):1375-8. PubMed ID: 26355276
[TBL] [Abstract][Full Text] [Related]
18. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, tumorigenic role, and biochemical implications of rare BRAF alterations.
Barollo S; Pezzani R; Cristiani A; Redaelli M; Zambonin L; Rubin B; Bertazza L; Zane M; Mucignat-Caretta C; Bulfone A; Pennelli G; Casal Ide E; Pelizzo MR; Mantero F; Moro S; Mian C
Thyroid; 2014 May; 24(5):809-19. PubMed ID: 24295088
[TBL] [Abstract][Full Text] [Related]
20. BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment.
Begum S; Rosenbaum E; Henrique R; Cohen Y; Sidransky D; Westra WH
Mod Pathol; 2004 Nov; 17(11):1359-63. PubMed ID: 15195111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
